Travere Therapeutics Inc (NAS:TVTX)
$ 6.42 -0.14 (-2.13%) Market Cap: 488.75 Mil Enterprise Value: 463.14 Mil PE Ratio: 0 PB Ratio: 6.62 GF Score: 58/100

Q2 2020 Retrophin Inc Earnings Call Transcript

Jul 30, 2020 / 08:30PM GMT
Release Date Price: $20.69 (+2.43%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Retrophin, Inc. Second Quarter Financial Results and Corporate Update Call. (Operator Instructions)

Chris Cline
Retrophin, Inc. - VP of IR & Corporate Communications

Hello?

Operator

Yes. This is the conference operator.

I apologize, Chris. I'm -- we're slowly getting people back into the subconference. And I will go ahead and transfer you and the ones who -- I'll go ahead and get everyone back into the subconference with you, and then I'll transfer everyone to the main.

(technical difficulty)

Chris Cline
Retrophin, Inc. - VP of IR & Corporate Communications

Thanks, Corey.

Operator

Ladies and gentlemen, thank you for standing by. I apologize for the delay and welcome to the Retrophin, Inc. Second Quarter Financial Results and Corporate Update Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot